We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMMV icon
51
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$292M
$386M 0.35%
11,167,452
+174,139
+2% +$5.98M
PEP icon
52
PepsiCo
PEP
$190B
$384M 0.35%
2,127,637
+16,180
+0.8% +$2.89M
COST icon
53
Costco
COST
$420B
$382M 0.35%
837,428
+68,060
+9% +$33.3M
USHY icon
54
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.1B
$377M 0.35%
10,909,892
+198,380
+2% +$6.86M
MDT icon
55
Medtronic
MDT
$112B
$366M 0.34%
4,703,123
+358,335
+8% +$29M
NEE icon
56
NextEra Energy
NEE
$177B
$364M 0.33%
4,354,068
+312,104
+8% +$25.2M
QQQ icon
57
Invesco QQQ Trust
QQQ
$481B
$348M 0.32%
1,305,783
-9,446
-0.7% -$2.61M
ABT icon
58
Abbott
ABT
$187B
$340M 0.31%
3,100,768
-66,761
-2% -$6.91M
MCD icon
59
McDonald's
MCD
$195B
$338M 0.31%
1,281,737
+44,585
+4% +$11.8M
VTV icon
60
Vanguard Morningstar Value ETF
VTV
$192B
$337M 0.31%
2,402,817
+225,703
+10% +$31.1M
SDY icon
61
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$323M 0.3%
2,585,383
+57,010
+2% +$7.04M
BAC icon
62
Bank of America
BAC
$442B
$314M 0.29%
9,475,344
+1,324,515
+16% +$45.6M
DHR icon
63
Danaher
DHR
$144B
$314M 0.29%
1,332,611
+205,044
+18% +$47.5M
QCOM icon
64
Qualcomm
QCOM
$176B
$312M 0.29%
2,838,677
-44,164
-2% -$5.17M
VEU icon
65
Vanguard FTSE All-World ex-US ETF
VEU
$70.2B
$308M 0.28%
6,134,554
-328,987
-5% -$16M
XOM icon
66
ExxonMobil
XOM
$634B
$306M 0.28%
2,771,713
-161,486
-6% -$17.3M
CVS icon
67
CVS Health
CVS
$122B
$302M 0.28%
3,241,377
+80,844
+3% +$7.8M
ORCL icon
68
Oracle
ORCL
$423B
$296M 0.27%
3,624,121
+90,235
+3% +$6.86M
KO icon
69
Coca-Cola
KO
$375B
$289M 0.27%
4,543,282
+92,333
+2% +$5.57M
XLP icon
70
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.7B
$271M 0.25%
3,635,107
+543,472
+18% +$39.6M
CRM icon
71
Salesforce
CRM
$158B
$270M 0.25%
2,036,011
+32,134
+2% +$4.69M
WMB icon
72
Williams Companies
WMB
$86.1B
$266M 0.24%
8,071,146
+928,532
+13% +$30.2M
VIG icon
73
Vanguard Dividend Appreciation ETF
VIG
$114B
$266M 0.24%
1,748,509
-29,541
-2% -$4.4M
PXD
74
DELISTED
Pioneer Natural Resource Co.
PXD
$264M 0.24%
1,156,118
+42,246
+4% +$10.3M
AMT icon
75
American Tower
AMT
$80.4B
$263M 0.24%
1,240,894
+81,886
+7% +$17M

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.